98%
921
2 minutes
20
Developmentally regulated brain proteins (drebrins) are highly expressed in brain where they may regulate actin filament formation in dendritic spines. Recently, the drebrin E2 isoform was detected in certain epithelial cell types including the gastric parietal cell. In gastric parietal cells, activation of HCl secretion is correlated with actin filament formation and elongation within intracellular canaliculi, which are the sites of acid secretion. The aim of this study was to define the pattern of drebrin expression in gland units in the intact rabbit oxyntic gastric mucosa and to initiate approaches to define the functions of this protein in parietal cells. Drebrin E2 expression was limited entirely or almost entirely to parietal cells and depended upon the localization of parietal cells along the gland axis. Rabbit drebrin E2 was cloned and found to share 86% identity with human drebrin 1a and to possess a number of cross-species conserved protein-protein interaction and phosphorylation consensus sites. Two-dimensional Western blot and phosphoaffinity column analyses confirmed that drebrin is phosphorylated in parietal cells, and several candidate phosphorylation sites were identified by mass spectrometry. Overexpression of epitope-tagged drebrin E2 led to the formation of microspikes and F-actin-rich ring-like structures in cultured parietal cells and suppressed cAMP-dependent acid secretory responses. In Madin-Darby canine kidney cells, coexpression of epitope-tagged drebrin and the Rho family GTPase Cdc42, which induces filopodial extension, produced an additive increase in the length of microspike projections. Coexpression of dominant negative Cdc42 with drebrin E2 did not prevent drebrin-induced microspike formation. These findings suggest that 1) drebrin can induce the formation of F-actin-rich membrane projections by Cdc42-dependent and -independent mechanisms; and that 2) drebrin plays an active role in directing the secretagogue-dependent formation of F-actin-rich filaments on the parietal cell canalicular membrane. Finally, the differential distribution of drebrin in parietal cells along the gland axis suggests that drebrin E2 may be an important marker of parietal cell differentiation and functionality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1152/ajpgi.00002.2005 | DOI Listing |
Unlabelled: Repeated exposure to stress disrupts cognitive processes, including attention and working memory. A key mechanism supporting these functions is the ability of neurons to sustain action potential firing, even after a stimulus is no longer present. How stress impacts this persistent neuronal activity is currently unknown.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Key Laboratory of Evidence Science, China University of Political Science and Law, Ministry of Education, Beijing, China.
Rationale: Large cell lung carcinoma (LCLC) is a rare undifferentiated malignant epithelial tumor of the lung. The diagnostic complexity of LCLC stems from its pronounced histological heterogeneity and diverse clinical presentation, particularly when extrapulmonary manifestations constitute the initial disease presentation, complicating early detection.
Patient Concerns: A 58-year-old smoker presented with acute-onset dizziness, lethargy, and communication difficulties lasting 1 day.
Am J Physiol Renal Physiol
September 2025
Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany.
Focal segmental glomerulosclerosis (FSGS) is a common glomerular pathology characterized by podocyte injury, which can lead to kidney failure. Among the factors contributing to podocyte damage are mutations in nuclear pore complexes (NPCs), which regulate nuclear-cytoplasmic transport of proteins and RNAs. Defective NPCs can accumulate in highly differentiated, non-dividing cells such as podocytes.
View Article and Find Full Text PDFAim: To evaluate the possibility of using serum markers of atrophy (pepsinogens - PG I and II) to form high-risk groups for gastric cancer (Operative Link for Gastritis Assessment - OLGA stage III-IV) depending on the etiology of gastritis.
Materials And Methods: A total of 237 (56 men and 181 women) patients were examined. All patients underwent a C-urea breath test, a blood test for GastroPanel (PG I, PG II, gastrin-17, antibodies to immunoglobulin G), a blood test for antibodies to gastric parietal cells.
Over the past decades, acid production in the stomach has been regulated mainly by proton pump inhibitors (PPIs). However, despite their widespread use and solid evidence base for efficacy, PPIs have pharmacokinetic and pharmacodynamic limitations, such as a slow onset of action, response variability (dependent on CYP2C19 polymorphisms), and the need for activation in an acidic environment. These restrictions underscore the need for innovative molecular approaches to inhibiting acid production, which led to the development of a fundamentally different mechanism of action - potassium-competitive acid blockers (P-CABs), first introduced into clinical practice in 2015.
View Article and Find Full Text PDF